Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

Hidehito Horinouchi on X: S1801: Neo- vs. adjuvant pembrolizumab for stage III-IV melanoma by @DrSapnaPatel. Striking EFS benefits by neoadjuvant! Simple but highly important clinical question. Expect that it is not limited

Frontiers Adjuvant immunotherapy in early-stage resectable non–small cell lung cancer: A new milestone

Advances in Adjuvant Therapy For Cutaneous Melanoma: Implications for Clinical Practice

Cancers, Free Full-Text

Recent Advances in the Treatment of Melanoma

Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial - The Lancet

Frontiers Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer

Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?